Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Marcel

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|March 4, 2008
Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarctionJaap Jan J Smit, Jan Paul Ottervanger, Robbert J Slingerland, et al.
Journal of the American College of Cardiology|September 15, 2004
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarctionNicolette M S K J Ernst, Harry Suryapranata, Kor Miedema, et al.
Annals of Clinical Biochemistry|July 11, 2006
Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarctionSaman Rasoul, Mark B Nienhuis, Jan Paul Ottervanger, et al.
American Heart Journal|February 15, 2011
Prehospital triage in the ambulance reduces infarct size and improves clinical outcomeSonja Postma, Jan-Henk E Dambrink, Menko-Jan de Boer, et al.
European Heart Journal|May 14, 2004
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trialArnoud W J van 't Hof, Nicolette Ernst, Menko-Jan de Boer, et al.
BMC Medicine|June 4, 2005
The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]Iwan C C van der Horst, Jan Paul Ottervanger, Arnoud W J van 't Hof, et al.
American Heart Journal|December 3, 2014
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trialVincent Roolvink, Saman Rasoul, Jan Paul Ottervanger, et al.
American Heart Journal|April 29, 2006
Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcomeJaap Jan J Smit, Nicolette M S K J Ernst, Robbert J Slingerland, et al.
American Heart Journal|December 15, 2010
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapyTon Heestermans, Arnoud W J van 't Hof, Jurriën M ten Berg, et al.
Cardiovascular Diabetology|July 20, 2016
Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitusMark W Kennedy, Eliza Kaplan, Rik S Hermanides, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|March 4, 2008
Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarctionJaap Jan J Smit, Jan Paul Ottervanger, Robbert J Slingerland, et al.
Journal of the American College of Cardiology|September 15, 2004
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarctionNicolette M S K J Ernst, Harry Suryapranata, Kor Miedema, et al.
Annals of Clinical Biochemistry|July 11, 2006
Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarctionSaman Rasoul, Mark B Nienhuis, Jan Paul Ottervanger, et al.
American Heart Journal|February 15, 2011
Prehospital triage in the ambulance reduces infarct size and improves clinical outcomeSonja Postma, Jan-Henk E Dambrink, Menko-Jan de Boer, et al.
European Heart Journal|May 14, 2004
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trialArnoud W J van 't Hof, Nicolette Ernst, Menko-Jan de Boer, et al.
BMC Medicine|June 4, 2005
The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]Iwan C C van der Horst, Jan Paul Ottervanger, Arnoud W J van 't Hof, et al.
American Heart Journal|December 3, 2014
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trialVincent Roolvink, Saman Rasoul, Jan Paul Ottervanger, et al.
American Heart Journal|April 29, 2006
Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcomeJaap Jan J Smit, Nicolette M S K J Ernst, Robbert J Slingerland, et al.
American Heart Journal|December 15, 2010
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapyTon Heestermans, Arnoud W J van 't Hof, Jurriën M ten Berg, et al.
Cardiovascular Diabetology|July 20, 2016
Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitusMark W Kennedy, Eliza Kaplan, Rik S Hermanides, et al.
Pageof 9